Thomas O Daniel
Director at Gossamer Bio, Inc. (GOSS)
Thomas O Daniel has filed 10 insider reports with the SEC since May 2021, as director at Gossamer Bio, Inc. (GOSS), director at Magenta Therapeutics, Inc. (DNTH) and director at Larimar Therapeutics, Inc. (LRMR). The latest filing, on September 25, 2026, reports grant or award at Gossamer Bio, Inc. (GOSS).
- Filings
- 10
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Thomas O Daniel is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $10.72 | Sep 25, 2026 | |||||
| Director | $84.55 | Jun 30, 2022 | |||||
| Director | $3.14 | May 17, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 23, 2026GOSSSEC Form 4 filed by Director Daniel Thomas OForm 4Grant or award
- Jun 4, 2026GOSSSEC Form 4 filed by Director Daniel Thomas OForm 4Grant or award
- Jun 25, 2025GOSSSEC Form 4 filed by Director Daniel Thomas OForm 4Grant or award
- Jun 6, 2024GOSSSEC Form 4 filed by Daniel Thomas OForm 4Grant or award
- Jun 8, 2023GOSSSEC Form 4 filed by Daniel Thomas OForm 4Grant or award
- Jun 9, 2022GOSSSEC Form 4 filed by Daniel Thomas OForm 4Grant or award
- Jun 28, 2022DNTHSEC Form 4 filed by Daniel Thomas OForm 4Grant or award
- Jun 9, 2021GOSSSEC Form 4 filed by Daniel Thomas OForm 4Grant or award
- Jun 1, 2021DNTHSEC Form 4 filed by Daniel Thomas OForm 4Grant or award
- May 12, 2021LRMRSEC Form 4 filed by Daniel Thomas OForm 4Grant or award
Compare Thomas O Daniel with
- Thomas O Daniel vs Russell Clayton1 shared
- Thomas O Daniel vs Jeffrey W Sherman1 shared
- Thomas O Daniel vs Thomas Edward Hamilton1 shared
- Thomas O Daniel vs Carole Ben-Maimon1 shared
- Thomas O Daniel vs Frank E Thomas1 shared
- Thomas O Daniel vs Joseph Truitt1 shared
Other insiders at the same companies
- Russell ClaytonLRMR
- Jeffrey W ShermanLRMR
- Thomas Edward HamiltonLRMR
- Carole Ben-MaimonLRMR
- Frank E ThomasLRMR
- Joseph TruittLRMR
- John B. Harlow Jr.LRMR
- Michael CelanoLRMR
- Gopi ShankarLRMR
- Ryan SavitzDNTH
- Sandra MilliganGOSS
- Gregory Austin CiongoliGOSS
- Skye DrynanGOSS
- John D QuiselGOSS
- Russell J. CoxGOSS
- Steven D NathanGOSS
Questions about Thomas O Daniel
- What is Thomas O Daniel's role at Gossamer Bio, Inc.?
- Thomas O Daniel reports to the SEC as director at Gossamer Bio, Inc. (GOSS), according to the latest filing on September 25, 2026. Thomas O Daniel has also filed as director at Magenta Therapeutics, Inc. (DNTH) and director at Larimar Therapeutics, Inc. (LRMR).
- Has Thomas O Daniel bought or sold stock recently?
- No open-market purchases or sales by Thomas O Daniel are on file. The filings report grant or award.
- How do I get alerts when Thomas O Daniel files?
- Follow Thomas O Daniel on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Thomas O Daniel filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Thomas O Daniel (SEC CIK 0001538894). Totals count each trade once, skipping amendments whose original is on file, from May 17, 2021 on. View on SEC EDGAR · Get this as JSON